Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous nasal mucosal epithelial cell sheet transplantation for middle ear mucosa regeneration
jRCT1090220316Completed
- Sponsor
- Hiromi Kojima
- Start
- Nov 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of autologous nasal mucosal epithelial cell sheet in Cholesteatoma and adhesive otitis media (2 arms), sponsored by Hiromi Kojima. Primary endpoints: Recurrence rate, Auditory activity and 1 more. Started Nov 2017; status: completed.
02
Drugs
autologous nasal mucosal epithelial cell sheet
03
Conditions
Cholesteatomaadhesive otitis media
Beyond the preview
Go deeper on jRCT1090220316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220316.